The Efficacy and Safety of Treatment of Chronic HCV Infection by Ombitasvir/Paritaprevir/Ritonavir with Ribavirin and its Effect on Complement C3 and C4 Levels

Volume 90, Issue 3, March 2022, Pages 65-72

MUSTAFA M. ALFIKI, M.Sc.; HANAN S. EL-ABHAR, Ph.D.; DALAAL M. ABDALLAH, Ph.D.; LINA E. KHEDR, Ph.D., M.D.

• View Article
• PDF 360.58 K
• View on SCiNiTO